Reaction
Haptoglobin Abnormal reporting signals
As of the last recalculation, Haptoglobin Abnormal appears in 92 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 416.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 48 | 416.8 | 417.2 |
| Ravulizumab | 5 | 88.5 | 88.5 |